ADMA Biologics, Inc. (ADMA)
9.545
-0.30
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics EPS Diluted (Quarterly) : 0.1642 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1642 |
| March 31, 2026 | 0.1889 |
| December 31, 2025 | 0.2025 |
| September 30, 2025 | 0.1489 |
| June 30, 2025 | 0.1376 |
| March 31, 2025 | 0.11 |
| December 31, 2024 | 0.455 |
| September 30, 2024 | 0.1467 |
| June 30, 2024 | 0.1324 |
| March 31, 2024 | 0.0753 |
| December 31, 2023 | -0.0781 |
| September 30, 2023 | 0.011 |
| June 30, 2023 | -0.0286 |
| March 31, 2023 | -0.0306 |
| December 31, 2022 | -0.0603 |
| September 30, 2022 | -0.0759 |
| June 30, 2022 | -0.0701 |
| March 31, 2022 | -0.1277 |
| December 31, 2021 | -0.0921 |
| September 30, 2021 | -0.1324 |
| June 30, 2021 | -0.1484 |
| March 31, 2021 | -0.1589 |
| December 31, 2020 | -0.2009 |
| September 30, 2020 | -0.1929 |
| June 30, 2020 | -0.2337 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2608 |
| December 31, 2019 | -0.178 |
| September 30, 2019 | -0.1928 |
| June 30, 2019 | -0.2531 |
| March 31, 2019 | -0.2819 |
| December 31, 2018 | -0.3892 |
| September 30, 2018 | -0.3265 |
| June 30, 2018 | -0.3453 |
| March 31, 2018 | -0.3933 |
| December 31, 2017 | -0.2865 |
| September 30, 2017 | -0.59 |
| June 30, 2017 | -0.55 |
| March 31, 2017 | -0.51 |
| December 31, 2016 | -0.35 |
| September 30, 2016 | -0.34 |
| June 30, 2016 | -0.50 |
| March 31, 2016 | -0.43 |
| December 31, 2015 | -0.4278 |
| September 30, 2015 | -0.48 |
| June 30, 2015 | -0.44 |
| March 31, 2015 | -0.37 |
| December 31, 2014 | -0.3835 |
| September 30, 2014 | -0.36 |
| June 30, 2014 | -0.43 |
| March 31, 2014 | -0.64 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Erasca, Inc. | -0.1416 |
| Krystal Biotech, Inc. | 1.786 |
| Vericel Corp. | 0.0422 |
| Emergent BioSolutions, Inc. | -3.492 |
| Exelixis, Inc. | 0.8166 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 37.82M |
| Revenue (Quarterly) | 124.40M |
| Total Expenses (Quarterly) | 86.57M |
| Enterprise Value | 2.285B |
| Gross Profit Margin (Quarterly) | 69.31% |
| Profit Margin (Quarterly) | 30.40% |
| Earnings Yield | 7.38% |
| Operating Earnings Yield | 9.46% |
| Normalized Earnings Yield | 7.446 |